Chitosan nanoparticles loaded with ribavirin, carboplatin, and thyme oil downregulate SNQ2, ERG11, CDR1, and MDR1 in Candida strains
Open Access
- 28 November 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 42633
Abstract
This study examined the effects of chitosan nanoparticles (CS-NPs) loaded with ribavirin (CS-R-NPs), carboplatin (CS-C-NPs), and Thymus vulgaris essential oil (CS-TV-NPs) on gene expression in Candida glabrata and Candida tropicalis. C. glabrata and C. tropicalis strains were obtained from Tarbiat Modares University. CS-NPs were synthesized via the ionic gelation method and characterized through dynamic light scattering, electrophoretic light scattering and transmission electron microscopy. Cytotoxicity was assessed via the MTT assay in fibroblasts. The minimum inhibitory concentrations (MICs) of the nanoparticle-encapsulated formulations were determined via the microdilution method per the CLSI-M27-A3/S4 guidelines. The gene expression of SNQ2 and ERG11 in C. glabrata and that of CDR1 and MDR1 in C. tropicalis was quantified via qRT‒PCR. CS-R-NPs, CS-C-NPs and CS-TV-NPs demonstrated high encapsulation efficiencies (81–91%), hydrodynamic diameters of approximately 286–298 nm, and positive zeta potentials (+ 33 to + 34 mV), with a spherical morphology and minimal aggregation. In vitro drug release extended over 64 h, with CS-TV-NPs achieving the highest cumulative release (60%). Cytotoxicity assays indicated that the CS-TV-NPs presented the highest IC50 (20.31 µg/ml). Compared with free drugs, encapsulated formulations significantly lowered the MIC values against C. glabrata and C. tropicalis, enhancing antifungal efficacy. qRT‒PCR confirmed notable downregulation of SNQ2 and ERG11 in C. glabrata and of CDR1 and MDR1 in C. tropicalis, with the most pronounced effects observed in the CS-NP-treated groups. CS-NPs significantly enhanced antifungal efficacy by reducing MIC values and downregulating resistance genes, highlighting their potential as effective drug delivery systems against Candida infections.Keywords
This publication has 81 references indexed in Scilit:
- Inhibition of Nucleotide Biosynthesis Potentiates the Antifungal Activity of Amphotericin BPLOS ONE, 2014
- Gallic acid loaded disulfide cross-linked biocompatible polymeric nanogels as controlled release system: synthesis, characterization, and antioxidant activityJournal of Biomaterials Science, Polymer Edition, 2012
- Candida and invasive candidiasis: back to basicsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Candida albicans, a major human fungal pathogenJournal of Microbiology, 2011
- Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against CandidaEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- The ATP‐binding cassette transporter–encoding gene CgSNQ2 is contributing to the CgPDR1‐dependent azole resistance of Candida glabrataMolecular Microbiology, 2008
- Cancer nanotechnology: opportunities and challengesNature Reviews Cancer, 2005
- Mechanisms of Azole Resistance in Clinical Isolates of Candida glabrata Collected during a Hospital Survey of Antifungal ResistanceAntimicrobial Agents and Chemotherapy, 2005
- Antifungal Activity of Nonantifungal DrugsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- In Vitro and In Vivo Effects of 14α-Demethylase ( ERG11 ) Depletion in Candida glabrataAntimicrobial Agents and Chemotherapy, 2001